Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: Ann Surg. 2017 Mar;265(3):604–608. doi: 10.1097/SLA.0000000000001761

Table 4.

Adjusted hazard ratio of post-listing mortality for HIV+ waitlist candidates, by donor type1

Characteristic Hazard Ratio 95% Confidence Interval p-value
Living donor transplant
  1-year (vs. waitlist) 0.15 0.03–0.72 0.02
  3-year (vs. waitlist) 0.13 0.03–0.62 0.01
  5-year (vs. waitlist) 0.18 0.04–0.87 0.03
Deceased donor transplant
  1-year (vs. waitlist) 0.53 0.36–0.80 0.002
  3-year (vs. waitlist) 0.44 0.26–0.73 0.002
  5-year (vs. waitlist) 0.23 0.10–0.50 < 0.001
Age, per 10 years 1.30 1.10–1.50 0.006
Race (ref, white)
  Black 0.59 0.42–0.83 0.002
  Hispanic 0.42 0.25–0.73 0.002
  Asian-American/PI 0.54 0.13–2.30 0.40
  Other 0.21 0.03–1.60 0.13
Diabetes (ref, none)
  Type 1 2.30 1.10–4.70 0.03
  Type 2 1.70 1.10–2.70 0.03
  Other 0.84 0.44–1.60 0.58
Primary payer (ref, Medicaid)
  Medicare 0.75 0.50–1.10 0.15
  Private/self 0.60 0.38–0.94 0.03
  Other 0.90 0.33–2.40 0.83
Albumin 0.81 0.66–1.00 0.07
Dialysis, per 10 years 1.90 1.40–2.70 < 0.001
Willingness to accept HCV+ donor 2.20 1.50–3.10 < 0.001
1

Model adjusted for: Transplant (Y/N), days post-transplant, age at listing, race, gender, ABO type, angina or coronary artery disease, BMI, cerebrovascular disease, diabetes type, drug-treated COPD, education level, malignancy, medical condition, peptic ulcer, physical capacity, primary payer type, total albumin, working for income, primary diagnosis, time on dialysis, PRA level, prior solid-organ transplant, prior kidney transplant, willingness to accept an HCV+ kidney